Suzhou Sano Precision Medicine

Suzhou Sano Precision Medicine is a biotechnology company specializing in precision oncology and molecular diagnostics. Founded in 2015 by experts from Harvard and Yale, the company provides comprehensive diagnostic solutions for hematologic and solid tumors, covering molecular subtyping, personalized treatment guidance, and minimal residual disease (MRD) monitoring. Their technology stack includes next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), and AI-driven bioinformatics. Sano operates a high-standard molecular pathology laboratory and collaborates with academic institutions like Soochow University on cancer biology research and the discovery of novel therapeutic targets.